What is SpinTech MRI?
SpinTech MRI, based in Michigan, is a quantitative magnetic resonance imaging (MRI) platform dedicated to accelerating and enhancing the diagnosis and treatment of Parkinson's, Alzheimer's, dementia, and other neurological diseases. The company's innovative approach aims to provide clearer insights into brain health, addressing critical unmet needs in neurodegenerative disease management.
How much funding has SpinTech MRI raised?
SpinTech MRI has raised a total of $6.5M across 1 funding round:
Series A
$6.5M
Series A (2022): $6.5M with participation from Level8 Ventures and Genesis Innovation Group’s Cultivate(MD) Capital Fund
Key Investors in SpinTech MRI
Level8 Ventures
Level8 Ventures is a firm operating within the Consumer Services industry, known for its investments in companies with significant growth potential.
Genesis Innovation Group’s Cultivate(MD) Capital Fund
Genesis Innovation Group’s Cultivate(MD) Capital Fund is an investment vehicle focused on supporting advancements in medical technology and healthcare solutions.
What's next for SpinTech MRI?
With its recent major strategic investment, SpinTech MRI is poised for significant growth and further development of its quantitative MRI platform. This capital infusion is expected to fuel advancements in diagnostic accuracy and treatment efficacy for a range of neurological disorders, potentially expanding its market reach and impact on patient care. The company's focus on enterprise-level funding suggests a trajectory towards broader clinical adoption and integration.
See full SpinTech MRI company page
